Interleukin-6 (IL-6) and C-reactive protein (CRP) concentration prior to total nephrectomy are prognostic factors in localized renal cell carcinoma (RCC)

Reports of Practical Oncology and Radiotherapy

Volumn 18, Issue 5, 2013, Pages 304-309

  Hrab, Michał ^a   Olek Hrab, Karolina ^a   Antczak, Andrzej ^a   Kwias, Zbigniew ^a   Milecki, Tomasz ^a  

^a POZNAN UNIVERSITY OF MEDICAL SCIENCES   (Poland)

Author keywords

C reactive protein; Interleukin 6; Nephrectomy; Prognostic factors; Renal cell carcinoma

Indexed keywords

C REACTIVE PROTEIN; INTERLEUKIN 6;

ADULT; AGED; ARTICLE; BLOOD SAMPLING; CANCER LOCALIZATION; CANCER STAGING; CONCENTRATION (PARAMETERS); DISTANT METASTASIS; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; NEPHRECTOMY; PROSPECTIVE STUDY; SURVIVAL TIME;

EID: 84883780272     PISSN: 15071367     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rpor.2013.06.002     Document Type: Article

References (31)

1. Wojciechowska U, Didkowska J, Zatoński W. Nowotwory złośliwe w Polsce w 2006.
2. Gisterek I., Lata E., Halon A., et al. Prognostic role of c-met expression in breast cancer patients. Rep Pract Oncol Radiotherapy 2011, 16:173-177.
3. Carman J., Strojan P. Nasopharyngeal carcinoma in Slovenia 1990-2003 (results of treatement with conventional two diemensional radiotherapy). Rep Pract Oncol Radiotherapy 2012, 17:71-78.
4. Li G., Feng G., Gentil-Perret A., Genin C., Tostain J. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer. J Urol 2008, 180(2):510-513. discussion 513-4.
5. Sabatino M., Kim-Schulze S., Panelli M.C., et al. Serum vascular endothelial growth factor and fibronectin predict clinical response to high-dose interleukin-2 therapy. J Clin Oncol 2009, 27(June (16)):2645-2652.
6. Zhao H., Ljungberg B., Grankvist K., et al. Gene expression profiling predicts survival in conventional renal cell carcinoma. PLoS Med 2006, 3(January (1)):e13.
7. Elis W.J. Epidemiology and etiology of renal cell carcinoma. Principles and practice of genitourinary oncology 1997, Lippincott-Raven, Philadelphia, PA. D. Red. Raghavan, H.I. Scher, S.A. Leibel, Lange (Eds.).
8. Ljungberg B. Prognostic markers in renal cell carcinoma. Curr Opin Urol 2007, 17:303-308.
9. Ramsey S., Lamb G.W., Aitchison M., et al. Prospective study of the relationship between the systemic inflammatory response, prognostic scoring systems and relapse-free and cancer-specific survival in patient undergoing potentially curative resection for renal cancer. BJU Int 2008, 101(8):959-963.
10. Ishikawa I., Saito Y., Shikura N., et al. Ten-year prospective study of the development of renal cell carcinoma in dialysis patient. Am J Kidney Dis 1990, 16:452-458.
11. Pepys M.B. C-reactive protein fifty years on. Lancet 1981, 317:653-657.
12. Mackiewicz A. Badanie mechanizmów regulujaogonekcych glikozylacjeogonek białek ostrej fazy. Immun Pol 1989, 14:103-127.
13. Szalai A.J., Agrawal A., Greenhough T.J., et al. C-reactive protein: structural biology, geneexpression, and host defense function. Immunol Res 1997, 16:127-136.
14. Kato K., Hitsuda Y., Kawasaki Y., et al. The value of serum C-reactive protein as a survival determinant in patients with advanced non-small-cell lung cancer. Nihon Kokyuki Gakkai Zasshi 2000, 38:575-580.
15. Kodama J., Miyagi Y., Seki N., et al. Serum C-reactive protein as a prognostic factor in patients with epithelial ovarian cancer. Eur J Obste Gynecol Reprod Biol 1999, 82:107-110.
16. Nozoe T., Saeki H., Sugimachi K. Significance of preoperative elevation of serum C-reactive protein as an indicator of prognosis in esophageal carcinoma. Am J Surg 2001, 182:197-201.
17. Nozoe T., Korenaga D., Futatsugi M., et al. Immunohistochemical expression of C-reactive protein in squamous cell carcinoma of the esophagus - significance as a tumor marker. Cancer Lett 2003, 192:89-95.
18. Shimada H., Nabeya Y., Okazumi S., et al. Elevation of preoperative serum C-reactive protein level is related to poor prognosis in esophageal squamous cell carcinoma. J Surg Oncol 2003, 83:248-252.
19. Zakrzewska I., Kozłowski L., Wojtukiewicz M. Ocena zmian steogonekżeń interleukiny 6 i białka C-reaktywnego u chorych na nowotwory piersi. Pol Merk Lek 2003, 86:115-117.
20. Lamb G.W., McMillan D.C., Ramsey S., et al. The relationship between the pre-operative systemic inflammatory response and cancer specific survival in patients undergoing potentially curative resection for renal clear cell cancer. Br J Cancer 2006, 94:781-784.
21. Lamb G., McArdle P., Ramsey S., et al. The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer. BJU Inter 2008, 102(6):756-761.
22. Masuda H., Kurita Y., Fukuta K., et al. Significant prognostic factors for 5-year survival after curative resection of renal cell carcinoma. Int J Urol 1998, 5:418-422.
23. Komai Y., Saito K., Sakai K., et al. Increased preoperative serum C-reactive protein level predicts poor prognostic in patients with localized renal cell carcinoma. BJU Int 2007, 99:77-80.
24. Fujikawa K., Matsui Y., Oka H., et al. Serum C-reactive protein level and the impact of cytoreductive surgery in patients with metastatic renal cell carcinoma. J Urol 1999, 162:1934-1937.
25. Miki S., Iwano M., Miki Y., et al. Interleukin-6-functions as an in vitro autocrine growth factor in renal cell carcinomas. FEBS Lett 1989, 250:607-610.
26. Takenawa J., Kaneko Y., Fukumato M., et al. Enhanced expression of interleukin-6 in primary human renal cell carcinoma. J Natl Cancer Inst 1991, 83:1668-1672.
27. Blay J.Y., Negrier S., Combaret V., et al. Serum level of interleukin 6 as a prognostic factor in metastatic renal cell carcinoma. Cancer Res 1992, 15(52):3317-3322.
28. Tsukamoto T., Kumamoto Y., Miyao N., Masumori N., Takahashi A., Yanase M. Interleukin-6 in renal cell carcinoma. J Urol 1992, 148:1778-1782.
29. Hamao T., Kanayama H., Kan M., et al. Serum level and gene expression of interleukin-6 and tumor necrosis factor - alpha in human renal cell carcinoma. Nippon Hinyoukika Gakkai Zasshi 1994, 85:563-570.
30. Johnson T.V., Abbasi A., Owen-Smith A., et al. Absolute preoperative C-reactive protein predicts metastasis and mortality in the first year following potentially curative nephrectomy for clear cell renal cell carcinoma. J Urol 2010, 183(2):480-485.
31. Kamemoto H. Significance of plasma interleukin-6 in the diagnosis of renal cell carcinoma. Hinyokika Kiyo 1993, 39:301-306.